IL148770A0 - The gene prv-1 and antibodies and pharmaceutical compositions for treating polycythemia vera - Google Patents

The gene prv-1 and antibodies and pharmaceutical compositions for treating polycythemia vera

Info

Publication number
IL148770A0
IL148770A0 IL14877000A IL14877000A IL148770A0 IL 148770 A0 IL148770 A0 IL 148770A0 IL 14877000 A IL14877000 A IL 14877000A IL 14877000 A IL14877000 A IL 14877000A IL 148770 A0 IL148770 A0 IL 148770A0
Authority
IL
Israel
Prior art keywords
prv
antibodies
gene
pharmaceutical compositions
polycythemia vera
Prior art date
Application number
IL14877000A
Other languages
English (en)
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Publication of IL148770A0 publication Critical patent/IL148770A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14877000A 1999-09-30 2000-09-29 The gene prv-1 and antibodies and pharmaceutical compositions for treating polycythemia vera IL148770A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947010A DE19947010A1 (de) 1999-09-30 1999-09-30 Das Gen PRV-1 und dessen Verwendung
PCT/EP2000/009594 WO2001023554A1 (de) 1999-09-30 2000-09-29 Das gen prv-1 und dessen verwendung

Publications (1)

Publication Number Publication Date
IL148770A0 true IL148770A0 (en) 2002-09-12

Family

ID=7923937

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14877000A IL148770A0 (en) 1999-09-30 2000-09-29 The gene prv-1 and antibodies and pharmaceutical compositions for treating polycythemia vera

Country Status (21)

Country Link
EP (1) EP1220920A1 (sk)
JP (1) JP2003510077A (sk)
KR (1) KR20020047191A (sk)
CN (1) CN1377408A (sk)
AU (1) AU1132401A (sk)
BG (1) BG106554A (sk)
BR (1) BR0014444A (sk)
CA (1) CA2387702A1 (sk)
CZ (1) CZ20021094A3 (sk)
DE (1) DE19947010A1 (sk)
EA (1) EA200200286A1 (sk)
EE (1) EE200200168A (sk)
HR (1) HRP20020269A2 (sk)
HU (1) HUP0203080A2 (sk)
IL (1) IL148770A0 (sk)
MX (1) MXPA02002800A (sk)
NO (1) NO20021498L (sk)
PL (1) PL354184A1 (sk)
SK (1) SK4262002A3 (sk)
WO (1) WO2001023554A1 (sk)
ZA (1) ZA200202379B (sk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
MX2014014166A (es) 2012-05-21 2015-03-03 Genentech Inc Metodos para mejorar la seguridad del transporte de la barrera hematoencefalica.
EP3638774B1 (en) * 2017-06-14 2024-08-07 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063088A2 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same
AU746956B2 (en) * 1997-05-06 2002-05-09 Zymogenetics Inc. Novel tumor antigens
DE19849044A1 (de) * 1998-10-23 2000-04-27 Univ Ludwigs Albert Das Gen PRV-1 und dessen Verwendung
KR100468978B1 (ko) * 1998-12-16 2005-02-02 제넨테크, 인크. 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산

Also Published As

Publication number Publication date
EP1220920A1 (de) 2002-07-10
AU1132401A (en) 2001-04-30
PL354184A1 (en) 2003-12-29
NO20021498D0 (no) 2002-03-26
WO2001023554A1 (de) 2001-04-05
SK4262002A3 (en) 2002-09-10
EA200200286A1 (ru) 2002-12-26
NO20021498L (no) 2002-05-23
BR0014444A (pt) 2002-06-11
HUP0203080A2 (hu) 2002-12-28
ZA200202379B (en) 2003-10-29
JP2003510077A (ja) 2003-03-18
HRP20020269A2 (en) 2003-06-30
CZ20021094A3 (cs) 2002-06-12
BG106554A (bg) 2003-01-31
EE200200168A (et) 2003-04-15
DE19947010A1 (de) 2001-04-05
KR20020047191A (ko) 2002-06-21
CA2387702A1 (en) 2001-04-05
MXPA02002800A (es) 2002-07-22
CN1377408A (zh) 2002-10-30

Similar Documents

Publication Publication Date Title
IL193615A0 (en) New azaindoles for inhibiting protein kinases and pharmaceutical composition comprising the same
IL162183A0 (en) Polymer-lipid delivery vehicles and methods for the preparation thereof
IL150224A0 (en) Lipopeptides and pharmaceutical compositions containing the same
IL150223A0 (en) Lipopeptides and pharmaceutical compositions containing the same
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
IL138990A0 (en) Matrices for drug delivery and methods for making and using the same
HK1045650B (zh) 藥物組合物
HK1080724A1 (en) Stabilized pharmaceutical composition in lyophilized form
HUP0104795A3 (en) Azabicycloalkanes as ccr5 modulators, pharmaceutical compositions comprising thereof and their use
PT1239829E (pt) Dispositivos para administração de fármacos com propriedades antiprogestativas
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0203325A3 (en) Bicyclic amino acids, pharmaceutical compositions containing them and their use
HUP0104762A3 (en) Pharmaceutical moxifloxacin compositions and process for their preparation
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
AU5326100A (en) Pharmaceutical compositions and methods for use
EP1180006A4 (en) COMPOSITIONS AND METHODS FOR PREPARING SUCH COMPOSITIONS FROM LEPIDIA
PL352159A1 (en) Pharmaceutical compositions containing antibody against the fas
IL138888A0 (en) Pharmaceutical composition and combination preparation for immunosuppressive therapy
IL156262A0 (en) Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same
IL145520A0 (en) Flame-retarding composition and process for the preparation thereof
HUP0101256A3 (en) Pharmaceutical composition having antitumor activity and process for the preparation thereof
AU4312101A (en) Secure delivery receptacle and method for using the same
IL148770A0 (en) The gene prv-1 and antibodies and pharmaceutical compositions for treating polycythemia vera
HUP0203310A3 (en) Stable pharmaceutical compositions comprising benzimidazol and method for the production thereof
EP1173192A4 (en) METHOD AND COMPOSITIONS FOR TARGETED MEDICINE ADMINISTRATION